The Synthetic Cannabinoid Ajulemic Acid Exerts Anti-Fibrotic Effects In Bleomycin-Induced Pulmonary Fibrosis

被引：0
|
作者：
Lucattelli, M. [1 ]
Selvi, E. [1 ]
Gonzales, E. Garcia [1 ]
Balistreri, E. [1 ]
Lorenzini, S. [1 ]
Fineschi, S. [1 ]
Galeazzi, M. [1 ]
Distler, J. H. [2 ]
Lungarella, G. [1 ]
机构：
[1] Univ Siena, Siena, Italy
[2] Univ Erlangen Nurnberg, Erlangen, Germany
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2013年 / 187卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A5649
引用
收藏
页数：1
相关论文
共 50 条
  • [11] SMAC Mimetic as potential anti-fibrotic therapy in an in vivo model of Bleomycin-induced Pulmonary Fibrosis
    Vanegas, Natalia-Del Pilar
    Rosas, Lorena
    Garcia, Paula Agudelo
    Scott, Stephanie
    Riley, Madeline
    Dale, Erica L.
    Calyeca, Jazmin
    Peters, Victor
    Kaestle, Marc
    Seither, Peter
    Mora, Ana L.
    Rojas, Mauricio
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [12] The anti-fibrotic agent SMP-534 attenuates bleomycin-induced pulmonary fibrosis in hamsters
    Tsujimura, Tsuyoshi
    Ono-Kishino, Michiko
    Nagamine, Jun
    Sugaru, Eiji
    Tokunaga, Teruhisa
    Kitoh, Makoto
    Nagata, Ryu
    Nakagawa, Tsutomu
    Taiji, Mutsuo
    BIOMEDICAL RESEARCH-TOKYO, 2009, 30 (03): : 177 - 182
  • [13] ANTI-FIBROTIC EFFECTS OF CYCLOPHOSPHAMIDE ON BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA
    Ozgen, M.
    Koca, S.
    Ustundag, B.
    Ozercan, I.
    Dagli, F.
    Isik, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S159 - S159
  • [14] A Synthetic Cannabinoid That Exerts A Potent Anti-Fibrotic Effect During The Fibrogenic Phase Of Bleomycin Lung
    Lucattelli, M.
    Fineschi, S.
    Selvi, E.
    Gonzalez, E. Garcia
    Bartalesi, B.
    De Cunto, G.
    Lorenzini, S.
    Galeazzi, M.
    Lungarella, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [15] Macrophage-based delivery of anti-fibrotic proteins alleviates bleomycin-induced pulmonary fibrosis in mice
    Liu, Huiying
    Yang, Cuiping
    Gao, Yun
    Zhang, Xueli
    Wang, Min
    Yu, Xinting
    Wang, Weidong
    Xie, Lixin
    Tang, Ping
    Yin, Xiushan
    Bai, Changqing
    Zhang, Luo
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2023, 8 (05)
  • [16] ANTI-FIBROTIC EFFECTS OF PROTEASOME INHIBITION ON BLEOMYCIN-INDUCED EXPERIMENTAL SCLERODERMA
    Koca, S.
    Ozgen, M.
    Ozercan, I.
    Dagli, F.
    Ustundag, B.
    Isi, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S102 - S103
  • [17] Aprepitant exerts anti-fibrotic effect via inhibition of TGF-?/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats
    Mohamed, Mervat Z.
    Baky, Mohamed F. Abed El
    Ali, Merhan E.
    Hafez, Heba M.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2022, 95
  • [18] Effects of a Leukotriene B4 Receptor Antagonist, an Anti-Inflammatory and Anti-Fibrotic Agent, on Bleomycin-Induced Pulmonary Fibrosis
    Izumo, T.
    Kondo, M.
    Nagara, N.
    Iritani, E.
    Tamaoki, J.
    Nagai, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [19] Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice
    Cai, Yan
    Kimura, Shioko
    PLOS ONE, 2015, 10 (11):
  • [20] Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
    Wang, Jie
    Ren, Yan
    Zheng, Xiufen
    Kang, Jiaqi
    Huang, Zhenqian
    Xu, Lizhi
    Wang, Yaping
    FRONTIERS IN PHARMACOLOGY, 2021, 12
12345